tert-Butyl (R)-2-formylazetidine-1-carboxylate

Catalog No.: 
ACSDGQ793
CAS No.: 
327605-04-9
Molecular Formula: 
C9H15NO3
Molecular Weight: 
185.22
tert-Butyl (R)-2-formylazetidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$659.00InquiryInquiry
250mg98%$1211.00InquiryInquiry
1g98%$2426.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (R)-2-formylazetidine-1-carboxylate
IUPAC Nametert-butyl (R)-2-formylazetidine-1-carboxylate
MDL No.0
Molecular FormulaC9H15NO3
Molecular Weight185.22
SMILESO=C(N1[C@@H](C=O)CC1)OC(C)(C)C
InChI KeyUEGGEIJWHPDPLL-SSDOTTSWSA-N
Synonym1-Azetidinecarboxylic acid, 2-formyl-, 1,1-dimethylethyl ester, (2R)-;tert-butyl (2R)-2-formylazetidine-1-carboxylate;tert-butyl (R)-2-formylazetidine-1-carboxylate;(R)-1-Boc-azetidine-2-carbaldehyde
CAS No.327605-04-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACSDGQ793 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTSQB368 route compound structure diagram
    ACTSQB368161511-90-6In Stock
  2. Then
  3. ACSDGQ793 route product structure diagram
    ACSDGQ793327605-04-9
Inquiry

2. ACSDGQ793 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBDKT218 route compound structure diagram
    ACBDKT218228857-58-7In Stock
  2. Then
  3. ACSDGQ793 route product structure diagram
    ACSDGQ793327605-04-9
Inquiry

3. ACSDGQ793 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSDGQ793 route product structure diagram
    ACSDGQ793327605-04-9
Inquiry

Comments (0)